PARP-1 inhibition to treat cancer, ischemia, inflammation

被引：20

作者：

Graziani, G

Battaini, F

Zhang, J

机构：

[1] Guilford Pharmaceut Inc, Baltimore, MD 21224 USA

[2] Univ Roma Tor Vergata, Dept Neurosci, Pharmacol Sect, I-00133 Rome, Italy

来源：

PHARMACOLOGICAL RESEARCH | 2005年 / 52卷 / 01期

关键词：

D O I：

10.1016/j.phrs.2005.02.007

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：1 / 4

页数：4

相关论文

共 25 条

[21] Chemopotentiation by PARP inhibitors in cancer therapy
Tentori, L
Graziani, G
[J]. PHARMACOLOGICAL RESEARCH, 2005, 52 (01) : 25 - 33
[22] Tentori L, 2005, INT J ONCOL, V26, P415
[23] Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci
Tulin, A
Spradling, A
[J]. SCIENCE, 2003, 299 (5606) : 560 - 562
[24] Poly(ADP-ribosyl)ation in asthma and other lung diseases
Virág, L
[J]. PHARMACOLOGICAL RESEARCH, 2005, 52 (01) : 83 - 92
[25] MICE LACKING ADPRT AND POLY(ADP-RIBOSYL)ATION DEVELOP NORMALLY BUT ARE SUSCEPTIBLE TO SKIN-DISEASE
WANG, ZQ
AUER, B
STINGL, L
BERGHAMMER, H
HAIDACHER, D
SCHWEIGER, M
WAGNER, EF
[J]. GENES & DEVELOPMENT, 1995, 9 (05) : 509 - 520